Cue Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	27.14	22.46	48.51	51.61	64.37
Short-Term Investments	-	-	-	24.68	-
Cash & Short-Term Investments	27.14	22.46	48.51	76.29	64.37
Cash Growth	20.82%	-53.71%	-36.41%	18.52%	-24.15%
Accounts Receivable	5.55	0.95	1.7	0.06	3.14
Other Receivables	1.9	-	-	-	-
Total Trade Receivables	7.45	0.95	1.7	0.06	3.14
Other Current Assets	2.4	1.73	1.24	0.84	0.95
Total Current Assets	36.98	25.14	51.45	77.19	68.47
Net Property, Plant & Equipment	4.32	4.84	7.12	10.7	11.92
Other Long-Term Assets	0.91	2.21	2.96	3.39	3.01
Total Assets	42.21	32.19	61.53	91.28	83.4
Accounts Payable	3.95	2.82	3.5	2.73	2.59
Accrued Expenses	1.61	2.91	4.14	3.55	4.62
Current Portion of Long-Term Debt	-	4.33	3.96	1.96	-
Current Portion of Leases	1.91	3.54	3.37	3.3	4.93
Unearned Revenue	5.34	0.09	2.11	-	0.65
Other Current Liabilities	0.69	-	-	-	-
Total Current Liabilities	13.49	13.69	17.08	11.55	12.79
Long-Term Debt	-	-	4.2	8.04	-
Long-Term Leases	2.29	1	3.16	6.02	5.12
Total Long-Term Liabilities	2.29	1	7.36	14.05	5.12
Total Liabilities	15.78	14.69	24.45	25.6	17.91
Common Stock	0.1	0.06	0.05	0.04	0.03
Additional Paid-in Capital	394.8	359.3	338.23	316.19	262.91
Accumulated Other Comprehensive Income	-	-	-	-0.1	-
Retained Earnings	-368.47	-341.86	-301.19	-250.46	-197.45
Shareholders' Equity	26.43	17.5	37.09	65.68	65.49
Total Liabilities & Equity	42.21	32.19	61.53	91.28	83.4
Total Debt	4.2	8.88	14.7	19.32	10.05
Net Cash (Debt)	22.94	13.58	33.82	56.97	54.32
Net Cash Growth	68.88%	-59.84%	-40.64%	4.89%	-30.11%
Net Cash Per Share	0.24	0.24	0.74	1.60	1.74
Book Value	26.43	17.5	37.09	65.68	65.49
Book Value Per Share	0.28	0.31	0.81	1.84	2.09
Tangible Book Value	26.43	17.5	37.09	65.68	65.49
Tangible Book Value Per Share	0.28	0.31	0.81	1.84	2.09

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q